Manufacturing review of the cangaroo envelope device history record for the reported lot reflects that all packaged and labeled units were quality released to distribution on 2/21/2020 having met all internal qc acceptance requirements.All sterilization processing records and bioburden testing results indicate a successful sterilization cycle, and passing results of lal and sterility bis allowed the subassembly to be released for further packaging and labeling activities.There were no non-conformances during manufacturing or sterilization potentially impacting final acceptance of this manufacturing lot.In lieu of a request for the oem supplier dhr review, it is noted that aziyo processes the non-sterile envelope materials including cutting, suturing, packaging and sterilizing the product.It is also noted that per the instructions for use (art-20662) provided with the packaged cangaroo envelope device, that infection is listed as a potential complication associated with the surgical procedure and usage of the cangaroo envelope.Although an exact cause of the reported infection cannot be conclusively determined, infection is a known complication associated with the surgical implantation of cieds and cangaroo envelope devices.Should aziyo receive any additional details related to this event, a supplemental report will be filed.
|